PubRank

Chuanhai Cao

Author PubWeight™ 39.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology 2012 2.08
2 Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. J Alzheimers Dis 2009 1.91
3 Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab 2012 1.16
4 Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice. J Alzheimers Dis 2010 1.16
5 Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain. J Neuroinflammation 2013 1.13
6 Lipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agents. J Med Chem 2012 1.10
7 Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res 2009 1.06
8 Non-hemolytic α-AApeptides as antimicrobial peptidomimetics. Chem Commun (Camb) 2011 1.05
9 Improvement of a low pH antigen-antibody dissociation procedure for ELISA measurement of circulating anti-Abeta antibodies. BMC Neurosci 2007 1.00
10 Abeta-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice. Neurobiol Dis 2006 0.97
11 Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice. BMC Neurosci 2004 0.97
12 γ-AApeptide-based small-molecule ligands that inhibit Aβ aggregation. Chem Commun (Camb) 2013 0.96
13 AApeptides as a new class of antimicrobial agents. Org Biomol Chem 2013 0.94
14 Lipidated cyclic γ-AApeptides display both antimicrobial and anti-inflammatory activity. ACS Chem Biol 2013 0.94
15 Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine. J Infect Dis 2003 0.93
16 Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling. J Pineal Res 2011 0.92
17 Caffeine and coffee as therapeutics against Alzheimer's disease. J Alzheimers Dis 2010 0.91
18 Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice. Vaccine 2005 0.90
19 Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65. Mol Cell Biol 2006 0.89
20 Cellular translocation of a γ-AApeptide mimetic of Tat peptide. Mol Pharm 2012 0.87
21 Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction. J Alzheimers Dis 2011 0.86
22 Helical Antimicrobial Sulfono-γ-AApeptides. J Med Chem 2015 0.84
23 Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease. Neurosci Lett 2010 0.84
24 Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol 2015 0.84
25 Phage-displayed mimotopes recognizing a biologically active anti-HIV-1 gp120 murine monoclonal antibody. J Acquir Immune Defic Syndr 2002 0.83
26 The development of antimicrobial a-AApeptides that suppress proinflammatory immune responses. Chembiochem 2014 0.82
27 Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein. Mol Cell Biol 2007 0.82
28 Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells. Neuropharmacology 2012 0.81
29 Short antimicrobial lipo-α/γ-AA hybrid peptides. Chembiochem 2014 0.81
30 Acupuncture-Induced Analgesia: The Role of Microglial Inhibition. Cell Transplant 2016 0.79
31 Efficacy of a therapeutic vaccine using mutated β-amyloid sensitized dendritic cells in Alzheimer's mice. J Neuroimmune Pharmacol 2012 0.79
32 The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review. BMC Neurosci 2008 0.78
33 Hippocampal neurogenesis and the brain repair response to brief stereotaxic insertion of a microneedle. Stem Cells Int 2013 0.78
34 Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP+PS1 mice. PLoS One 2012 0.78
35 Modulation of infection and type 1 cytokine expression parameters by morphine during in vitro coinfection with human T-cell leukemia virus type I and HIV-1. J Acquir Immune Defic Syndr 2003 0.77
36 Cellular uptake of an α-AApeptide. Org Biomol Chem 2011 0.77
37 Pilot study of granulocyte-colony stimulating factor for treatment of Alzheimer's disease. J Alzheimers Dis 2012 0.77
38 Evaluation of an α synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson disease. Hum Vaccin Immunother 2015 0.77
39 The traditional Chinese medicinal formula BDL301 suppresses tumor growth by inhibiting STAT3 pathway and inducing apoptosis in colorectal cancer cells. DNA Cell Biol 2015 0.76
40 Brain-derived Neurotrophic Factor Signaling Pathway: Modulation by Acupuncture in Telomerase Knockout Mice. Altern Ther Health Med 2015 0.76
41 Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease. Hum Vaccin Immunother 2014 0.75
42 Transient Micro-needle Insertion into Hippocampus Triggers Neurogenesis and Decreases Amyloid Burden in a Mouse Model of Alzheimer's Disease. Cell Transplant 2016 0.75
43 Simplified enrichment and identification of environmental peptide toxins using antibody-capture surfaces with subsequent mass spectrometry detection. J Chromatogr A 2006 0.75